February 2020
SMA Europe
Posters & Presentations
October 2019
World Muscle Society Congress
SRK-015, a Fully Human Monoclonal Antibody Inhibiting Myostatin Activation, Offers Sustained Target Engagement Across Multiple Species, Including Humans
April 2019
American Association for Cancer Research (AACR) Annual Meeting
Defeating primary checkpoint resistance: SRK-181 is a first-in-class, fully human antibody that renders resistant tumors sensitive to anti-PD-1
November 2018
The Society for Immunotherapy of Cancer (SITC) 33rd Annual Meeting
Defeating checkpoint resistance: Highly specific inhibition of latent TGFβ1 activation renders resistant solid tumors vulnerable to PD-1 blockade
October 2018
12th International BMP Conference
RGMc-selective antibodies modulate iron homeostasis in vivo
March 2018
Gordon Research Conference